NASA Lunar Test Confirms AstroRad Vest Slashes Radiation Exposure During Solar Storms

Researchers have confirmed that the AstroRad radiation-shielding vest significantly reduces astronaut exposure to deep-space radiation, according to results from a test flight to the Moon and back. The data, gathered during NASA's uncrewed Artemis I mission in 2022, suggests the wearable technology can provide critical protection during severe solar particle events.

The test utilized two female manikins, Zohar and Helga, to evaluate the vest's efficacy. Zohar wore the AstroRad vest, while Helga served as a control without shielding. Simulations based on the flight data indicate that the vest could reduce radiation doses by approximately 60% during a solar storm similar to the 1972 event and by nearly 40% during one mirroring the 1989 event. Jordan Houri of StemRad described the effort as the largest experiment ever conducted to determine astronaut radiation exposure beyond low-Earth orbit.

Targeted Protection

Developed by Lockheed Martin and the U.S.-Israeli startup StemRad, the AstroRad vest was modeled after specialized gear used by nuclear disaster response teams. Unlike traditional spacecraft shielding, which requires heavy materials to protect the entire cabin, the vest employs a targeted approach. It is designed specifically to shield the most radiation-vulnerable organs and tissues, including the bone marrow, lungs, stomach, breasts, and ovaries.

The decision to use female manikins for the Artemis I test was intentional. Researchers sought to specifically address the increased risk of radiation-induced cancers in women, ensuring that the shielding is effective for all crew members regardless of biological vulnerability.

Implications for Deep Space

Deep space radiation, particularly from unpredictable solar storms, remains one of the primary health hurdles for long-duration spaceflight. While Earth's magnetic field protects the surface, crews on lunar or Martian missions are exposed to higher levels of ionizing radiation, which increases the risk of radiation sickness and long-term cancer development.

The success of the AstroRad vest demonstrates that wearable protection can effectively mitigate these risks without the prohibitive weight and cost of heavily shielding an entire spacecraft. This capability is critical as NASA transitions from short-term lunar flybys to the establishment of permanent moon bases and eventual crewed expeditions to Mars.

Future Outlook

With the validation of the Artemis I data, the focus now shifts to integrating wearable shielding into standard crew protocols for future deep-space missions. While the simulations provide a strong proof of concept for solar storm mitigation, further testing will likely be required to optimize the vest for the diverse radiation environments encountered during multi-year journeys to Mars.